Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis. Bogdanos DP, Gilbert D, Bianchi I, Leoni S, Mitry RR, Ma Y et al. J Autoimmune Dis 2004; 1(1):4. – DOI: 10.1186/1740-2557-1-4

more Information

Autoimmune liver serology: Current diagnostic and clinical challenges. Bogdanos DP, Invernizzi P, Mackay IR, Vergani D. World J Gastroenterol 2008 June 7; 14(21): 3374-3387 – DOI: 10.3748/wjg.14.3374

more Information

Disease-specific autoantibodies in primary biliary cirrhosis. Bogdanos DP and Komorowski L. Clin Chim Acta 412 (7-8):502-512, 2011.

more Information

Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. D. P. Bogdanos, C. Liaskos, A. Pares, G. Norman, E. I. Rigopoulou, L. Caballeria, G. N. Dalekos, J. Rodes, and D. Vergani. Hepatology 45 (6):1583-1584, 2007.

more Information

Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. Granito A, Muratori L, Muratori P, Pappas G, Guidi M, Cassani F, Volta U, Ferri A, Lenzi M, and Bianchi FB. J Clin.Pathol. 59 (3):280-284, 2006.

more Information

Primary biliary cirrhosis: what do autoantibodies tell us? Hu CJ, Zhang FC, Li YZ, and Zhang X. World J Gastroenterol. 16 (29):3616-3629, 2010.

more Information

Autoimmune hepatitis. Krawitt EL. N Engl J Med 2006; 354(1):54-66

more Information

Autoimmune hepatitis, from mechanisms to therapy. Manns MP, Vogel A. Hepatology 2006; 43(2 Suppl 1):S132-S144. – DOI 10.1002/hep.21059

more Information

The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis. McFarlane,I.G. Gut 1998;42:599–602

more Information

The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome Muratori P, Granito A, Pappas G, Pendino GM, Quarneti C, Cicola R, Menichella R, Ferri S, Cassani F, Bianchi FB, Lenzi M, and Muratori L. Am J Gastroenterol. 104 (6):1420-1425, 2009.

more Information

Non-muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virus- associated chronic liver diseases Mühlen vCA, Chan EK, Peebles CL, Imai H, Kiyosawa K, and Tan EM. Clin Exp Immunol. 1995 April; 100(1): 67–74.

more Information

Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis. Rigopoulou EI, Mytilinaiou M, Romanidou O, Liaskos C, and Dalekos GN. J Autoimmune.Dis 4:2, 2007.

more Information

Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Vergani D, Alvarez F, Bianchi FB, Cancado EL, Mackay IR, Manns MP, Nishioka M, and Penner E. Group J Hepatol. 41 (4):677-683, 2004.

more Information

Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis. Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, K.H. et al. Lancet 2000; 355(9214):1510-5. – DOI:10.1016/S0140-6736(00)02166-8

more Information

Antinuclear antibodies specific for primary biliary cirrhosis. Worman HJ and Courvalin JC. Autoimmun.Rev 2 (4):211-217, 2003.

more Information

Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. Zachou K, Rigopoulou E, Dalekos GN. Journal of Autoimmune Diseases 2004, 1:2 – DOI:10.1186/1740- 2557-1-2

more Information

Anti-smooth muscle antibodies (ASMAs) and anti-cytoskeleton antibodies (ACTAs) in liver diseases: a comparison of classical indirect immunofluorescence with ELISA. Zamanou A, Tsirogianni A, Terzoglou C, Balafas A, Economidou I, Lymberi P. J Clin Lab Anal 2002; 16(4):194-201.

more Information

Cookies erleichtern die Bereitstellung unserer Dienste. Mit der Nutzung unserer Dienste erklären Sie sich damit einverstanden, dass wir Cookies verwenden.
Weitere Informationen Ok